Waters Corporation reported second quarter 2026 total revenue of $1.645 billion and adjusted EPS of $3.05, exceeding analyst expectations for its core business. Organic revenue, which excludes recent acquisitions, grew 9% in constant currency to $828 million, driven by a broadening market recovery.
Key Highlights
- Organic revenue grew 9% in constant currency to $828 million, outperforming expectations due to strong growth in the Analytical Sciences Division.
- The company raised its full-year 2026 guidance, now expecting organic constant currency revenue growth of 7% to 9% and adjusted EPS of $14.45 to $14.65.
- Recently acquired Biosciences and Diagnostic Solutions businesses contributed $817 million in revenue, growing 4% on a prior year comparable basis.
- Adjusted EPS for the second quarter increased 3% year-over-year to $3.05, landing at the high end of the company's guidance range.